Schnieders Capital Management LLC Amgen Inc Transaction History

Schnieders Capital Management LLC

$518 Million
Q3 2024

A detailed history of Schnieders Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Schnieders Capital Management LLC holds 22,082 shares of AMGN stock, worth $6.08 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

22,082

Previous 22,581 2.21%

Holding current value

$6.08 Million

Previous $7.06 Million 0.85%

% of portfolio

1.37%

Previous 1.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $154,380 - $168,352	-499 Reduced 2.21%	22,082 $7.12 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $148,979 - $181,048	-567 Reduced 2.45%	22,581 $7.06 Million
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $21,509 - $25,964	80 Added 0.35%	23,148 $6.58 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $446,196 - $503,362	-1,745 Reduced 7.03%	23,068 $6.64 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $27,549 - $34,203	-126 Reduced 0.51%	24,813 $6.67 Million
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $22,069 - $26,097	103 Added 0.41%	24,939 $5.54 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $88,283 - $107,603	391 Added 1.6%	24,836 $6 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $57,257 - $72,752	250 Added 1.03%	24,445 $6.42 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $499,423 - $563,258	2,225 Added 10.13%	24,195 $5.45 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $176,493 - $196,406	-765 Reduced 3.36%	21,970 $5.35 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $3,069 - $3,395	-14 Reduced 0.06%	22,735 $5.5 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $384,236 - $439,723	1,932 Added 9.28%	22,749 $5.12 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $38,208 - $44,766	180 Added 0.87%	20,817 $4.43 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $322,573 - $357,872	1,381 Added 7.17%	20,637 $5.03 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $71,011 - $82,752	320 Added 1.69%	19,256 $4.79 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $43,276 - $51,534	200 Added 1.07%	18,936 $4.35 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $31,677 - $35,228	-135 Reduced 0.72%	18,736 $4.76 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $59,936 - $73,550	-303 Reduced 1.58%	18,871 $4.45 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $132,124 - $175,232	-725 Reduced 3.64%	19,174 $3.89 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $104,065 - $133,760	550 Added 2.84%	19,899 $4.8 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $406,198 - $486,710	-2,333 Reduced 10.76%	19,349 $3.74 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $273,054 - $320,081	1,638 Added 8.17%	21,682 $4 Million
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $108,522 - $122,328	-600 Reduced 2.91%	20,044 $3.81 Million
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $4,460 - $5,206	25 Added 0.12%	20,644 $4.02 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $92,645 - $104,445	-500 Reduced 2.37%	20,619 $4.27 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $70,903 - $79,639	-427 Reduced 1.98%	21,119 $3.9 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $153,334 - $179,190	905 Added 4.38%	21,546 $3.67 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $33,758 - $37,718	200 Added 0.98%	20,641 $3.59 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $3.42 Million - $3.9 Million	20,441	20,441 $3.81 Million

Others Institutions Holding AMGN

# of Institutions

3,078

Shares Held

405M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schnieders Capital Management LLC with notifications on news.

Account

Schnieders Capital Management LLC Amgen Inc Transaction History